BTK Inhibitors in B-Cell Malignancies: Expert Perspectives to Guide Clinical Decisions

Review key strategies for integrating BTK inhibition into management of your patients with B-cell malignancies with downloadable slides from a live expert-led meeting series.

Share

Program Content

Activities

BTK Inhibition in B-Cell Malignancies
Leveraging BTK Inhibition Strategies in B-Cell Malignancies: Expert Perspectives to Guide Clinical Decisions
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 26, 2020

Expires: June 25, 2021

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.

Janssen administered by Scientific Affairs